Drugs / VCL-IPT1
last change Feb 2011 re-read 3 minutes ago

VCL-IPT1

Developed for
influenza
Investigated by
Vical

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00694213 Aug 2007 → Sep 2008 influenza Vical Completed No outcome recorded
Phase 1 NCT00709800 Aug 2007 → Sep 2008 influenza Vical Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as VCL-IPT1 “VCL-IPT1” NCT00694213 ↗
1

NCT00709800 ↗

Route Intramuscular “IM, 1 mg/mL, 2 injections, 0 and 21 days” NCT00694213 ↗